Attune Health Research, Inc.
Quick facts
Phase 3 pipeline
- Acthar Injectable Product · Immunology / Rheumatology
Acthar is a synthetic adrenocorticotropic hormone (ACTH) that stimulates the adrenal cortex to produce and release cortisol and other corticosteroids.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: